Botulinum toxin from Revance Therapeutics — who it suits, where it is used, and what it should cost
Quick answer
Daxxify is a botulinum toxin from Revance Therapeutics (United States). It uses a proprietary peptide carrier instead of human albumin, letting the molecule stay bound at the nerve terminal longer. Results typically last 5–7 months in good responders. Reference pricing is about ไม่มีราคาตลาดอย่างเป็นทางการ (US reference roughly 18,000–25,000 baht per treatment) in Thailand versus roughly ไม่มีราคาตลาดอย่างเป็นทางการ (US reference roughly 18,000–25,000 baht per treatment) in Korea. A Thailand–Korea comparison is not possible while the product is unregistered in both markets. Registration: Thailand — No registration found; Korea — No registration found.
Daxxify signals where the toxin category is heading: competing on duration rather than price. If such products reach Asia, per-session cost will be higher but annual sessions fewer, so buyers should think in cost-per-year rather than cost-per-visit.
Technically, it is engineered for longer duration, with US registration data reporting a median around six months for glabellar lines. That matters because it dictates how firm or soft the product feels, how far it spreads and which tissue plane it belongs in. Experienced injectors pick the sub-model to match the site rather than choosing on brand name alone.
Popular placement: glabellar lines as the core indication, with off-label use elsewhere in permitted markets. Good planning starts from a whole-face assessment rather than filling only the spot the patient points at, because balance comes from distributing volume sensibly, not from maximising one area.
On longevity, Daxxify typically holds 5–7 months in good responders. It fades sooner with a fast metabolism, frequent intense exercise, smoking, highly mobile areas such as lips and perioral skin, and under-dosing relative to what the face actually needs. It lasts longer with correct plane placement, a sub-model matched to local tissue pressure, and a top-up before the effect disappears completely.
Who it suits: people tired of quarterly sessions who live in a market where the product is approved.
Not suitable or best avoided: patients in Thailand or Korea today, since no registration is on file in either market — any local offer should be treated as a red flag. This also covers pregnancy and breastfeeding, active infection at the injection site, and any known allergy to the product's components.
Thailand versus Korea: reference market pricing runs about ไม่มีราคาตลาดอย่างเป็นทางการ (US reference roughly 18,000–25,000 baht per treatment) in Thailand and roughly ไม่มีราคาตลาดอย่างเป็นทางการ (US reference roughly 18,000–25,000 baht per treatment) in Korea. A Thailand–Korea comparison is not possible while the product is unregistered in both markets. The honest comparison includes travel cost — flights, accommodation, interpreting and time. For a single small treatment the gap rarely covers a trip; combined with several procedures in one visit, the difference starts to matter.
For Thai readers planning treatment, the safe position today is simple: if a clinic in Thailand or Korea offers Daxxify, verify registration first. Product imported outside official channels carries no guarantee on quality, storage or liability if something goes wrong.
Safety and authenticity: A longer duration means that any side effect such as brow drop also lasts longer, so conservative dosing is wise. Before treatment, ask to see the sealed box and label, check the registration number against Thailand's FDA or Korea's MFDS, photograph the lot number and expiry, and have the doctor open the product in front of you. A price far below market is usually a sign of unregistered stock or over-dilution.
Bottom line: Daxxify is worth it when it is matched to a real concern, injected by a doctor who reads the whole face, and understood as a temporary result that needs maintenance rather than a one-off fix. Compare prices per unit or per cc of registered product — never a promotional price against a standard one.
Last updated: 2026-09-03 · This content is for information only and is not medical advice. Consult a qualified doctor before making treatment decisions.